AVTX

Avalo Therapeutics News

Company Name Stock Ticker Symbol Market Type
Avalo Therapeutics Inc AVTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.1888 3.64% 5.3688 13:57:51
Open Price Low Price High Price Close Price Prev Close
5.44 5.00 5.5821 5.18
more quote information »

Recent News

Date Time Source Heading
8/08/202207:23EDGARAmended Statement of Ownership (sc 13g/a)
8/04/202207:41EDGARQuarterly Report (10-q)
8/04/202207:38EDGARCurrent Report Filing (8-k)
8/04/202207:30GLOBEAvalo Reports Second Quarter 2022 Financial Results..
8/02/202207:30GLOBEAvalo Therapeutics Announces First Patient Dosed in the..
8/01/202207:00GLOBEAvalo Therapeutics Transfers Anti-IL-18 Antibody, AVTX-007..
7/06/202216:05GLOBEAvalo Therapeutics Announces One-for-Twelve Reverse Stock..
7/01/202216:08EDGARStatement of Changes in Beneficial Ownership (4)
7/01/202216:01EDGARStatement of Changes in Beneficial Ownership (4)
6/16/202216:02EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202216:32EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202216:16EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202216:02EDGARCurrent Report Filing (8-k)
6/02/202207:30GLOBEAvalo to Present at the 2022 Jefferies Healthcare Conference
5/24/202207:04EDGARCurrent Report Filing (8-k)
5/18/202207:30GLOBEAvalo Therapeutics Announces First Patient Dosed in the..
5/17/202215:46EDGARStatement of Ownership (sc 13g)
5/17/202207:30GLOBEAvalo to Present at the H.C. Wainwright Global Life Sciences..
5/05/202207:30GLOBEAvalo Therapeutics First Quarter 2022 Financial Results..
4/25/202216:05EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/25/202216:02EDGARProxy Statement (definitive) (def 14a)
4/04/202218:07EDGARStatement of Changes in Beneficial Ownership (4)
4/04/202217:38EDGARStatement of Changes in Beneficial Ownership (4)
3/18/202216:06EDGARCurrent Report Filing (8-k)
3/16/202207:32EDGARCurrent Report Filing (8-k)
3/14/202217:39EDGARStatement of Changes in Beneficial Ownership (4)
3/10/202217:38EDGARStatement of Changes in Beneficial Ownership (4)
3/08/202207:00GLOBEAvalo to Present at Oppenheimer's 32nd Annual Healthcare..
3/07/202218:10EDGARStatement of Changes in Beneficial Ownership (4)
3/02/202216:10EDGARAnnual Report (10-k)
3/02/202207:49SEEKAvalo Therapeutics GAAP EPS of -$0.83 in-line, revenue of..
3/02/202207:30GLOBEAvalo Therapeutics Reports 2021 Financial Results..
2/18/202216:02EDGARCurrent Report Filing (8-k)
2/17/202208:12SEEKAvalo Therapeutics picks internal candidate for CEO and CFO..
2/17/202207:30GLOBEAvalo Therapeutics Announces Leadership Transition
2/14/202217:02EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202208:07EDGARAmended Statement of Ownership (sc 13g/a)
2/07/202216:01GLOBEAvalo Therapeutics to Present at the 2022 BIO CEO and..
1/20/202218:15EDGARStatement of Changes in Beneficial Ownership (4)
1/14/202217:50EDGARStatement of Changes in Beneficial Ownership (4)
1/11/202218:19EDGARStatement of Changes in Beneficial Ownership (4)
1/11/202203:32SEEKNew commercial chief at Avalo Therapeutics
1/10/202219:58GLOBEAvalo Therapeutics Appoints Stephen Smolinski as Chief..
1/09/202220:55TRMNAvalo Therapeutics (AVTX) Gets a Buy Rating from RBC Capital
1/06/202216:20EDGARStatement of Changes in Beneficial Ownership (4)
1/06/202216:17EDGARInitial Statement of Beneficial Ownership (3)
1/06/202210:24SEEKAvalo Therapeutics discontinues multiple myeloma program;..
1/06/202207:56EDGARCurrent Report Filing (8-k)
1/06/202207:30GLOBEAvalo Reports Positive Phase 1b Results for AVTX-002 in..
1/04/202216:28EDGARStatement of Changes in Beneficial Ownership (4)


Your Recent History
NASDAQ
AVTX
Avalo Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now